let's answer
ls "/tmp/workspace/attachments/5eba3352-9574-4987-9143-a6a66e87f053/"
python3 -c " from docx import Document doc = Document('/tmp/workspace/attachments/5eba3352-9574-4987-9143-a6a66e87f053/Y3_Neuro_non-infectious_student1 (1).docx') for p in doc.paragraphs: style = p.style.name if p.style else 'None' if p.text.strip(): print(f'[{style}] {p.text}') "
python3 -c " from docx import Document doc = Document('/tmp/workspace/attachments/5eba3352-9574-4987-9143-a6a66e87f053/Y3_Neuro_non-infectious_student1 (1).docx') for i, table in enumerate(doc.tables): print(f'=== TABLE {i+1} ===') for row in table.rows: cells = [cell.text.strip() for cell in row.cells] print(' | '.join(cells)) print() "
| # | Diagnosis | Reasoning |
|---|---|---|
| 1 | Acute ischemic stroke (left MCA territory) - most likely | Sudden-onset expressive aphasia with right arm/leg weakness (3/5) and left facial droop. She is right-handed, so the LEFT hemisphere is language-dominant. The left MCA supplies Broca's area (inferior frontal gyrus). Hypertension (12 years) plus an irregular heart rhythm (likely AF) are major risk factors. |
| 2 | Intracerebral hemorrhage (ICH) | Also causes sudden focal neurological deficits. Long-standing hypertension is the classic risk factor for hypertensive bleeds (typically basal ganglia, thalamus). Cannot be excluded without non-contrast CT. |
| 3 | Embolic stroke from atrial fibrillation | The heart is described as "irregular" - highly suspicious for atrial fibrillation. AF allows thrombus formation in the left atrial appendage; emboli travel preferentially into the MCA territory because it receives the largest proportion of carotid flow. This may overlap with diagnosis #1 (the mechanism behind the ischemic stroke). |
Key point: CT head without contrast is the first-line imaging - it rules out hemorrhage immediately. If negative, the diagnosis shifts to ischemic stroke and time-to-treatment (tPA window) becomes urgent.
| Feature | Intracerebral Hemorrhage | Ischemic - Thrombotic | Ischemic - Embolic |
|---|---|---|---|
| Basic mechanism | Rupture of a cerebral blood vessel; blood accumulates within brain tissue | Thrombus forms over an atherosclerotic plaque within a cerebral artery, causing progressive occlusion | Embolus forms elsewhere (heart, aorta, carotid) and lodges in a distal cerebral artery |
| Typical onset | Sudden; often worsens over minutes-hours as hematoma expands | May be gradual or "stuttering" - symptoms can fluctuate or build over hours | Abrupt, often maximal at onset (the embolus arrives all at once) |
| Headache | Common and often severe ("worst headache") | Usually absent or mild | Usually absent |
| Vomiting | More common (raised ICP) | Less common | Less common |
| Level of consciousness | More likely impaired, especially with large hemorrhage or intraventricular extension | Usually preserved unless massive infarction | Usually preserved initially |
| Neurological deficits | Focal + mass effect; hemiparesis, aphasia, visual deficits; often severe | Focal deficits matching the vascular territory | Focal cortical deficits (aphasia, visual field cut, neglect) matching the artery |
| Major risk factors | Chronic hypertension, cerebral amyloid angiopathy, anticoagulation, AVM | Atherosclerosis, hypertension, diabetes, hyperlipidemia, smoking, older age | Atrial fibrillation, recent MI, valvular disease (mitral stenosis), ventricular thrombus |
| Typical locations | Basal ganglia, thalamus, pons, cerebellum (hypertensive); lobar (amyloid angiopathy) | Large cerebral arteries (MCA, ACA); can cause lacunar infarcts in small penetrating vessels | MCA most common (receives ~80% of ICA flow); any artery possible |
| CT imaging | Hyperdense (bright white) blood immediately visible | Normal initially; may show subtle early ischemic signs (loss of gray-white differentiation, dense MCA sign) | Normal initially; infarction appears as hypodensity after 6-24 hours |
| Classic example | Hypertensive patient with sudden headache, vomiting, hemiparesis, declining consciousness | Patient with known carotid stenosis develops gradually worsening unilateral limb weakness | Patient with known AF suddenly develops aphasia and hemiplegia - as in this case |
| Presentation | Risk factors | Associated conditions | |
|---|---|---|---|
| Intracerebral hemorrhage | Sudden severe headache, nausea/vomiting, focal deficits, decreased consciousness; may worsen rapidly | Hypertension (most common), anticoagulant use, amyloid angiopathy, AVM, cocaine/stimulants | Hypertension, coagulopathy, cerebral amyloid angiopathy (elderly), AVMs |
| Ischemic (thrombotic) | Focal deficits in a vascular territory; may be preceded by TIA; onset can be stuttering; often on waking | Atherosclerosis, hypertension, diabetes mellitus, dyslipidemia, smoking, older age | Carotid artery disease, coronary artery disease, peripheral vascular disease, metabolic syndrome |
| Ischemic (embolic) | Abrupt onset, often maximal at onset; cortical signs prominent (aphasia, neglect, hemianopia); may have sudden improvement (lysis) | Atrial fibrillation, valvular disease, recent MI, dilated cardiomyopathy, endocarditis | Atrial fibrillation, structural heart disease, deep vein thrombosis (paradoxical embolism via PFO) |
| Finding on Exam | Stroke (UMN) | Bell's Palsy (LMN) |
|---|---|---|
| Forehead wrinkle (raise eyebrow) | Preserved on affected side | Absent - cannot wrinkle forehead |
| Eye closure | Mild weakness; can usually close eye | Incomplete eye closure (lagophthalmos) |
| Lower face droop | Present (contralateral to lesion) | Present (ipsilateral to nerve lesion) |
| Tongue deviation | May be present (CN XII involvement) | Not affected |
| Other neurological signs | Often present: arm/leg weakness, aphasia, sensory loss | Absent (pure facial nerve lesion) |
| Hyperacusis | Absent | May be present (stapedius weakness) |
| Taste loss (anterior 2/3 tongue) | Absent | May be present (chorda tympani) |
| Ear pain (retroauricular) | Absent | Common early symptom |


| Symptoms | Artery | Side of Occlusion |
|---|---|---|
| Behavior changes + left lower leg weakness | Anterior Cerebral Artery (ACA) | Right ACA |
| Vision loss | Posterior Cerebral Artery (PCA) | Contralateral to the visual field deficit |
| Headache + nystagmus + slurred speech | Basilar Artery | N/A (midline/bilateral brainstem) |
| Right facial droop + right arm weakness | Middle Cerebral Artery (MCA) | Left MCA |
labs and tests if symptoms resolved
| Study | What it tells you | Priority |
|---|---|---|
| Non-contrast CT head | Rules out hemorrhage, mass lesion, tumor (TIA mimics); usually normal in TIA | First, immediate |
| MRI brain with DWI (diffusion-weighted imaging) | Detects acute ischemic infarction even when CT is normal. About 33% of "TIAs" show infarction on DWI - changing the diagnosis to stroke. Also detects old infarcts and leukoaraiosis. | Urgent, same-day if possible |
| CT Angiography (CTA) or MR Angiography (MRA) of head and neck | Evaluates for carotid stenosis, intracranial stenosis, arterial dissection - the structural cause of ischemia | Urgent |
| Carotid duplex ultrasound | Non-invasive assessment of carotid bifurcation stenosis; relevant because carotid endarterectomy is most beneficial within 2 weeks of TIA | Urgent (if CTA/MRA not available) |
Key point from Tintinalli's: "positive findings on DWI have predictive value for subsequent early stroke risk in TIA patients, as does cervical vascular imaging by MRA."
| Study | What it tells you |
|---|---|
| ECG (12-lead) | Most important first cardiac test. Rules in/out atrial fibrillation, recent MI, other arrhythmias. This patient has an "irregular" heart - AF must be confirmed or excluded. |
| Telemetry / continuous cardiac monitoring | AF is paroxysmal and can be missed on a single ECG. Inpatient monitoring catches intermittent AF. |
| Prolonged cardiac monitoring (Holter 24-48h or 30-day event monitor) | Detects occult AF in up to 25% of cryptogenic strokes when short monitoring is negative. Especially relevant here given the irregular rhythm. |
| Transthoracic echocardiogram (TTE) | Evaluates left ventricular function (thrombus), valvular disease (mitral stenosis), wall motion abnormalities (post-MI source), patent foramen ovale (PFO). |
| Transesophageal echocardiogram (TEE) | Better visualization of the left atrial appendage (where AF thrombi form), aortic arch plaques, and PFO. Indicated when TTE is non-diagnostic and cardioembolic source is suspected. |
| Lab | Rationale |
|---|---|
| Complete Blood Count (CBC) | Thrombocytosis (clotting risk), polycythemia (hyperviscosity), anemia (reduced O2 delivery), thrombocytopenia (bleeding risk before antiplatelet therapy) |
| Basic Metabolic Panel (BMP) | Electrolytes and glucose - hypoglycemia is the most important TIA/stroke mimic and must be excluded immediately. Renal function guides contrast use for CTA. |
| Glucose / HbA1c | Diabetes is a major stroke risk factor; HbA1c establishes long-term glycemic control |
| Lipid panel (fasting) | LDL level guides statin therapy (high-intensity statin is part of secondary prevention after TIA/stroke) |
| PT/INR and aPTT | Coagulation status; baseline before initiating anticoagulation or antiplatelet therapy |
| Thyroid-stimulating hormone (TSH) | Hyperthyroidism causes AF; hypothyroidism contributes to atherosclerosis |
| Cardiac biomarkers (troponin) | Rule out concurrent ACS (stroke and MI can co-occur); also, large strokes can cause troponin elevation via catecholamine surge |
| Factor | Points |
|---|---|
| Age ≥ 60 years | 1 |
| Blood pressure ≥ 140/90 mmHg at presentation | 1 |
| Clinical features: unilateral weakness | 2 |
| Clinical features: speech disturbance without weakness | 1 |
| Duration ≥ 60 minutes | 2 |
| Duration 10-59 minutes | 1 |
| Diabetes mellitus | 1 |
| Total | 0-7 |
Important caveat: The American College of Emergency Physicians (2016 guidelines) stated that ABCD2 alone should NOT be used to decide safe discharge - it is inadequate as a standalone risk stratification tool. Most high-risk TIA patients should be admitted.
retry
| Study | Purpose | Timing |
|---|---|---|
| Non-contrast CT head | First-line: rules out hemorrhage, tumor, abscess (TIA mimics). Usually normal in TIA. | Immediate |
| MRI brain with DWI (diffusion-weighted imaging) | The key test. Detects acute ischemic infarction even when CT is normal - ~33% of "TIAs" show infarction on DWI, reclassifying them as strokes. Also shows old infarcts and white matter disease. Patients with DWI lesions have significantly higher early stroke risk. | Same-day, urgent |
| MRA or CTA of head and neck | Evaluates for carotid stenosis, intracranial stenosis, arterial dissection - identifies the structural source of ischemia and guides whether carotid endarterectomy is needed. Carotid ultrasound is an alternative if CTA/MRA unavailable. | Urgent |
From Bradley and Daroff's Neurology: "Patients with TIA and DW-MRI lesions are at greater early risk for experiencing a subsequent stroke than patients without a lesion."
| Study | Purpose |
|---|---|
| 12-lead ECG | First cardiac test. Confirms or rules out atrial fibrillation, identifies recent MI, LVH from hypertension. |
| Continuous telemetry monitoring | AF is paroxysmal - a single ECG misses it. Inpatient monitoring detects intermittent AF. |
| Transthoracic echocardiogram (TTE) | Evaluates LV function, wall motion abnormalities, valvular disease (mitral stenosis), intracardiac thrombus, and patent foramen ovale (PFO). |
| Transesophageal echocardiogram (TEE) | Better visualization of the left atrial appendage (where AF thrombi form), aortic arch plaques, and PFO with bubble study. Used when TTE is non-diagnostic. |
| Prolonged cardiac monitoring (24-48h Holter or 30-day event monitor) | Detects occult paroxysmal AF in up to 25% of cryptogenic strokes when initial monitoring is negative. |
| Test | Rationale |
|---|---|
| Glucose (STAT) | Hypoglycemia is the #1 TIA/stroke mimic - must be excluded immediately at bedside |
| CBC with differential and platelets | Thrombocytosis or polycythemia (hyperviscosity/clotting risk); thrombocytopenia (bleeding risk before antiplatelet therapy); anemia (reduced O2 delivery) |
| BMP (electrolytes, BUN, creatinine) | Electrolyte abnormalities can cause neurological symptoms; renal function guides use of contrast for CTA and dosing of medications |
| PT / INR and aPTT | Baseline coagulation before starting antithrombotic therapy |
| Fasting lipid panel | LDL level guides intensity of statin therapy - high-intensity statin is part of secondary prevention |
| HbA1c | Establishes baseline glycemic control; diabetes is a major stroke risk factor |
| TSH | Hyperthyroidism causes AF; hypothyroidism accelerates atherosclerosis |
| Cardiac troponin | Rules out concurrent ACS; large strokes can also elevate troponin via catecholamine surge |
| Test | Rationale |
|---|---|
| Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin Ab) | Hypercoagulable state, especially in younger patients |
| Factor V Leiden, Prothrombin G20210A, Protein C/S, Antithrombin III | Inherited thrombophilia screen |
| ESR / CRP, ANA | Vasculitis |
| Blood cultures / echocardiography | If infective endocarditis suspected |
| Urine toxicology screen | Cocaine/stimulants cause vasospasm and stroke |
| RPR / VDRL | Neurosyphilis |
| Factor | This Patient | Points |
|---|---|---|
| Age > 60 | 72 years | 1 |
| BP > 140/90 | 155/89 | 1 |
| Clinical features: unilateral weakness | Yes (R arm/leg 3/5) | 2 |
| Duration ≥ 60 min | ~1 hour | 2 |
| Diabetes | Not mentioned | 0 |
| Total | 6 / 7 |
Important caveat: The American College of Emergency Physicians (2016) states ABCD2 alone should not be used to discharge patients. It is a helpful tool but cannot independently confirm safety for outpatient management.